Donald Tashkin

2 months ago | jamanetwork.com | Donald Tashkin |Tyler Gallagher |Ryan Chung |Matthew Lin

Clarification Regarding the Association of Cannabis Use and Head and Neck Cancer To the Editor I have concerns regarding the conclusions of Gallagher et al.1 Using data extracted from electronic medical records (EMRs) and databases from 64 US health organizations that covered a 20-year period, the authors created 2 cohorts of patients, 1 with and the other without cannabis-related use disorder based on otherwise similar propensity-matched characteristics, including age, self-reported race and...

Dec 23, 2024 | acrjournals.onlinelibrary.wiley.com | Elizabeth R Volkmann |Holly Wilhalme |Donald Tashkin |Jonathan Goldin |Alana Haussmann |Masataka Kuwana | +2 more

Supporting Information Filename Description acr25485-sup-0001-Disclosureform.pdfPDF document, 671.5 KB Disclosure Form acr25485-sup-0002-supinfo.docxWord 2007 document , 331.1 KB Supporting Information

Dec 5, 2024 | digitalcommons.library.tmc.edu | David Roofeh |Kevin Brown |Ella Kazerooni |Donald Tashkin

OBJECTIVES: To establish a framework by which experts define disease subsets in systemic sclerosis associated interstitial lung disease (SSc-ILD). METHODS: A conceptual framework for subclinical, clinical and progressive ILD was provided to 83 experts, asking them to use the framework and classify actual SSc-ILD patients.

May 7, 2024 | digitalcommons.library.tmc.edu | Elizabeth R Volkmann |Donald Tashkin |Michael Roth |Ning Li

OBJECTIVE: To investigate the prevalence of the MUC5B promoter variant rs35705950 in patients with systemic sclerosis-interstitial lung disease (SSc-ILD) and whether its presence predicts response to immunosuppression with cyclophosphamide (CYC) and mycophenolate (MMF). METHODS: SSc-ILD patients who participated in Scleroderma Lung Study (SLS) II (MMF versus CYC) were included in this study (N = 142).

Oct 5, 2023 | thorax.bmj.com | Elizabeth R Volkmann |Donald Tashkin

Outcomes of systemic sclerosis associated interstitial lung disease patients with a persistent inflammatory phenotype based on serial CRP measurements Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.